Dicer is involved in protection against influenza A virus infection

被引:85
|
作者
Matskevich, Alexey A. [1 ]
Moelling, Karin [1 ]
机构
[1] Univ Zurich, Inst Med Virol, CH-8006 Zurich, Switzerland
来源
关键词
D O I
10.1099/vir.0.83103-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In mammals the interferon (IFN) system is a central innate antiviral defence mechanism, while the involvement of RNA interference (RNAi) in antiviral response against RNA viruses is uncertain. Here, we tested whether RNAi is involved in the antiviral response in mammalian cells. To investigate the role of RNAi in influenza A virus-infected cells in the absence of IFN, we used Vero cells that lack IFN-alpha and IFN-beta genes. Our results demonstrate that knockdown of a key RNAi component, Dicer, led to a modest increase of virus production and accelerated apoptosis of influenza A virus-infected cells. These effects were much weaker in the presence of IFN. The results also show that in both Vero cells and the IFN-producing alveolar epithelial A549 cell line influenza A virus targets Dicer at mRNA and protein levels. Thus, RNAi is involved in antiviral response, and Dicer is important for protection against influenza A virus infection.
引用
收藏
页码:2627 / 2635
页数:9
相关论文
共 50 条
  • [41] Identification of host cell factors involved in influenza A virus infection
    Bavagnoli, Laura
    Maga, Giovanni
    FUTURE VIROLOGY, 2013, 8 (02) : 195 - 208
  • [42] Protection against influenza virus challenge by topical application of influenza DNA vaccine
    Watabe, S
    Xin, KQ
    Ihata, A
    Liu, LJ
    Honsho, A
    Aoki, I
    Hamajima, K
    Wahren, B
    Okuda, K
    VACCINE, 2001, 19 (31) : 4434 - 4444
  • [43] Vaccination with recombinant PIV5 expressing influenza neuraminidase provides protection against homologous and heterologous influenza virus infection
    Tompkins, Stephen
    Mooney, Alaina
    Li, Zhou
    Gabbard, Jon
    Dlugolenski, Daniel
    Johnson, Scott
    Tripp, Ralph
    He, Biao
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [44] Effects of frequent intranasal administration of adjuvant-combined influenza vaccine on the protection against virus infection
    Tamura, S
    Yajima, A
    Hatori, E
    Tamura, S
    Asanuma, H
    Suzuki, Y
    Aizawa, C
    Kurata, T
    VACCINE, 1997, 15 (16) : 1784 - 1790
  • [45] TIV Vaccination Modulates Host Responses to Influenza Virus Infection that Correlate with Protection against Bacterial Superinfection
    Choi, Angela
    Christopoulou, Ioanna
    Saelens, Xavier
    Garcia-Sastre, Adolfo
    Schotsaert, Michael
    VACCINES, 2019, 7 (03)
  • [46] Protection against influenza virus infection by intranasal administration of C3d-fused hemagglutinin
    Watanabe, I
    Ross, TM
    Tamura, S
    Ichinohe, T
    Ito, S
    Takahashi, H
    Sawa, H
    Chiba, J
    Kurata, T
    Sata, T
    Hasegawa, H
    VACCINE, 2003, 21 (31) : 4532 - 4538
  • [47] Novel correlates of protection against pandemic H1N1 influenza A virus infection
    Ng, Sophia
    Nachbagauer, Raffael
    Balmaseda, Angel
    Stadlbauer, Daniel
    Ojeda, Sergio
    Patel, Mayuri
    Rajabhathor, Arvind
    Lopez, Roger
    Guglia, Andrea F.
    Sanchez, Nery
    Amanat, Fatima
    Gresh, Lionel
    Kuan, Guillermina
    Krammer, Florian
    Gordon, Aubree
    NATURE MEDICINE, 2019, 25 (06) : 962 - +
  • [48] MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection
    O'Hagan, Derek T.
    EXPERT REVIEW OF VACCINES, 2007, 6 (05) : 699 - 710
  • [49] PROTECTION OF MICE AGAINST ASIAN INFLUENZA-VIRUS INFECTION BY A NORMAL HORSE-SERUM INHIBITOR
    COHEN, A
    LANCET, 1960, 2 (OCT8): : 791 - 794
  • [50] PROTECTION AGAINST INFLUENZA-A VIRUS-INFECTION IN MICE BY ORAL IMMUNIZATION WITH A POLYVALENT BACTERIAL LYSATE
    VANDAAL, GJ
    BEUSENBERG, FD
    SO, KL
    FIEVEZ, RBAM
    SPRENGER, MJW
    MOUTON, JW
    VANTVEEN, A
    LACHMANN, B
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1991, 13 (07): : 831 - 840